Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Klier

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Der Urologe. Ausg. A|July 12, 2017
[Metastatic prostate cancer : Update: position paper for the use of chemotherapy]C-H Ohlmann, P J Goebell, M-O Grimm, et al.
Der Urologe. Ausg. A|October 11, 2019
[Radium-223 for the treatment of metastatic castration-resistant prostate cancer (mCRPC) : The androgen receptor-independent active agent in the therapeutic sequence]F König, A Strauß, M Johannsen, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Der Urologe. Ausg. A|July 12, 2017
[Metastatic prostate cancer : Update: position paper for the use of chemotherapy]C-H Ohlmann, P J Goebell, M-O Grimm, et al.
Der Urologe. Ausg. A|October 11, 2019
[Radium-223 for the treatment of metastatic castration-resistant prostate cancer (mCRPC) : The androgen receptor-independent active agent in the therapeutic sequence]F König, A Strauß, M Johannsen, et al.
Pageof 2